MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,382,000 | +0.4% | 50,745 | +5.5% | 0.95% | -4.3% |
Q3 2019 | $1,377,000 | +8.0% | 48,113 | +4.8% | 1.00% | +12.5% |
Q2 2019 | $1,275,000 | -4.4% | 45,903 | +14.2% | 0.88% | -14.7% |
Q1 2019 | $1,334,000 | +13.5% | 40,185 | -0.6% | 1.04% | +0.4% |
Q4 2018 | $1,175,000 | -36.0% | 40,426 | +1.2% | 1.03% | -25.8% |
Q3 2018 | $1,836,000 | +4.9% | 39,929 | -14.8% | 1.39% | +9.4% |
Q2 2018 | $1,751,000 | +26.1% | 46,856 | -0.3% | 1.27% | +17.8% |
Q1 2018 | $1,389,000 | -53.8% | 46,989 | -46.3% | 1.08% | -11.0% |
Q4 2017 | $3,008,000 | +116.9% | 87,554 | +93.1% | 1.21% | -16.0% |
Q2 2016 | $1,387,000 | +1.2% | 45,341 | +23.8% | 1.45% | -0.3% |
Q1 2016 | $1,371,000 | -7.7% | 36,619 | +5.3% | 1.45% | -13.2% |
Q4 2015 | $1,486,000 | +11.1% | 34,783 | -3.3% | 1.67% | +12.4% |
Q3 2015 | $1,338,000 | +13.8% | 35,952 | +4.0% | 1.49% | +21.8% |
Q2 2015 | $1,176,000 | -51.9% | 34,569 | -51.7% | 1.22% | +4.8% |
Q1 2015 | $2,444,000 | +96.1% | 71,510 | +95.5% | 1.17% | -0.3% |
Q4 2014 | $1,246,000 | – | 36,580 | – | 1.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |